Two Sigma Advisers’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-175,400
| Closed | -$175K | – | 2443 |
|
2024
Q3 | $175K | Sell |
175,400
-19,000
| -10% | -$19K | ﹤0.01% | 2102 |
|
2024
Q2 | $241K | Sell |
194,400
-17,400
| -8% | -$21.6K | ﹤0.01% | 2152 |
|
2024
Q1 | $275K | Sell |
211,800
-2,900
| -1% | -$3.77K | ﹤0.01% | 2100 |
|
2023
Q4 | $268K | Sell |
214,700
-28,800
| -12% | -$36K | ﹤0.01% | 2139 |
|
2023
Q3 | $317K | Sell |
243,500
-91,400
| -27% | -$119K | ﹤0.01% | 1963 |
|
2023
Q2 | $576K | Buy |
334,900
+86,700
| +35% | +$149K | ﹤0.01% | 1763 |
|
2023
Q1 | $362K | Sell |
248,200
-6,400
| -3% | -$9.34K | ﹤0.01% | 2071 |
|
2022
Q4 | $412K | Sell |
254,600
-5,900
| -2% | -$9.56K | ﹤0.01% | 1953 |
|
2022
Q3 | $873K | Buy |
260,500
+62,200
| +31% | +$208K | ﹤0.01% | 1588 |
|
2022
Q2 | $722K | Buy |
198,300
+184,800
| +1,369% | +$673K | ﹤0.01% | 1756 |
|
2022
Q1 | $98K | Sell |
13,500
-7,600
| -36% | -$55.2K | ﹤0.01% | 2509 |
|
2021
Q4 | $287K | Buy |
+21,100
| New | +$287K | ﹤0.01% | 2157 |
|